Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 201–300 of 786
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Mulligan, M. J., & Landau, N. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.02.450959 · Cited by 51
Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
Zhang, W., Shi, K., Geng, Q., Ye, G., Aihara, H., & Li, F. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206509119 · Cited by 53
SARS-CoV-2 variants: biology, pathogenicity, immunity and control
Uraki, R., Korber, B., Diamond, M., & Kawaoka, Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01255-x · Cited by 62
Huang, S., & Wang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063060 · Cited by 56
Çelik, İ., Yadav, R., Düzgün, Z., Albogami, S. M., El‐Shehawi, A. M., Fatimawali, F., Idroes, R., Tallei, T. E., & Emran, T. B. (2021) · Biology · doi:10.3390/biology10090880 · Cited by 52
Andrade, A. C. D. S. P., Campolina-Silva, G. H., Queiroz‐Junior, C. M., de Oliveira, L. C., Lacerda, L. D. S. B., Pimenta, J. C., Resende, F., Chaves, I. D. M., Passos, I. B. S., Teixeira, D. C., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01276-21 · Cited by 52
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Yao, Z., Zhang, L., Duan, Y., Tang, X., & Lü, J. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106121 · Cited by 52
On the road to ending the COVID-19 pandemic: Are we there yet?
Case, J. B., Winkler, E. S., Errico, J. M., & Diamond, M. (2021) · Virology · doi:10.1016/j.virol.2021.02.003 · Cited by 49
Shionoya, K., Yamasaki, M., Iwanami, S., Ito, Y., Fukushi, S., Ohashi, H., Saso, W., Tanaka, T., Aoki, S., Kuramochi, K., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651403 · Cited by 49
Chakraborty, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108424 · Cited by 50
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 51
SARS-CoV-2 in animals: From potential hosts to animal models
Michelitsch, A., Wernike, K., Ulrich, L., Mettenleiter, T. C., & Beer, M. (2021) · Advances in virus research · doi:10.1016/bs.aivir.2021.03.004 · Cited by 52
Feng, Q., Cheng, K., Zhang, L., Wang, D., Gao, X., Liang, J., Liu, G., Ma, N., Chen, X., Tang, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53937-4 · Cited by 48
Self-citationPaidi, R. K., Jana, M., Mishra, R. K., Dutta, D., Raha, S., & Pahan, K. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09979-8 · Cited by 46
Maurin, M., Fenollar, F., Mediannikov, O., Davoust, B., Devaux, C. A., & Raoult, D. (2021) · Microorganisms · doi:10.3390/microorganisms9040868 · Cited by 51
Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
Mehraeen, E., Dadras, O., Afsahi, A. M., Karimi, A., MohsseniPour, M., Mirzapour, P., Barzegary, A., Behnezhad, F., Habibi, P., Salehi, M. A., et al. (2021) · Infectious Disorders - Drug Targets · doi:10.2174/1871526521666210923144837 · Cited by 47
COVID-19: From emerging variants to vaccination
Senevirathne, T. H., Wekking, D., Swain, J. W. R., Solinas, C., & Silva, P. D. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.11.005 · Cited by 52
SARS-CoV-2 Rapidly Adapts in Aged BALB/c Mice and Induces Typical Pneumonia
Zhang, Y., Huang, K., Wang, T., Deng, F., Gong, W., Hui, X., Zhao, Y., He, X., Li, C., Zhang, Q., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02477-20 · Cited by 48
Umair, M., Ikram, A., Salman, M., Haider, S. A., Badar, N., Rehman, Z., Ammar, M., Rana, M. S., & Ali, Q. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27429 · Cited by 49
Yan, F., Li, E., Wang, T., Li, Y., Liu, J., Wang, W., Qin, T., Su, R., Pei, H., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821664 · Cited by 50
Self-citationKuroda, T., Nobori, H., Fukao, K., Baba, K., Matsumoto, K., Yoshida, S., Tanaka, Y., Watari, R., Oka, R., Kasai, Y., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad027 · Cited by 44
He, C., Yang, H. J., He, X., Hong, W., Hong, L., Chen, Z., Shen, G., Yang, L., Li, J., Wang, Z., et al. (2021) · MedComm · doi:10.1002/mco2.72 · Cited by 43
Self-citationHighly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice
Asaka, M. N., Utsumi, D., Kamada, H., Nagata, S., Nakachi, Y., Yamaguchi, T., Kawaoka, Y., Kuba, K., & Yasutomi, Y. (2021) · JCI Insight · doi:10.1172/jci.insight.152529 · Cited by 40
Fidan, Ö., Mujwar, S., & Kciuk, M. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10440-6 · Cited by 44
Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity
Zhou, W., Xu, C., Wang, P., Anashkina, A. A., & Jiang, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab375 · Cited by 45
Rathnasinghe, R., Jangra, S., Ye, C., Čupić, A., Singh, G., Martínez‐Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30763-0 · Cited by 43
SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
Huang, H., Zhu, Y., Niu, Z., Zhou, L., & Sun, Q. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00846-4 · Cited by 43
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Hall, M. D., Anderson, J. M., Anderson, A. S., Baker, D. A., Bradner, J. E., Brimacombe, K. R., Campbell, E. A., Corbett, K. S., Carter, K. L., Cherry, S. R., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab305 · Cited by 41
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
Rawle, D. J., Le, T. T., Dumenil, T. D., Yan, K., Tang, B., Nguyen, W., Watterson, D., Modhiran, N., Hobson‐Peters, J., Bishop, C., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009723 · Cited by 44
Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
Sanclemente-Alamán, I., Moreno‐Jiménez, L., Benito‐Martín, M. S., Canales-Aguirre, A. A., Matías‐Guiu, J. A., Matías‐Guiu, J., & Gómez‐Pinedo, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02163 · Cited by 41
Flores-Alanis, A., Cruz‐Rangel, A., Rodríguez‐Gómez, F., González, J., Torres-Guerrero, C. A., Delgado, G., Cravioto, A., & Morales-Espinosa, R. (2021) · Pathogens · doi:10.3390/pathogens10020184 · Cited by 43
Lee, P., Kim, C.-U., Seo, S. H., & Kim, D. (2021) · Immune Network · doi:10.4110/in.2021.21.e4 · Cited by 42
SARS‐CoV‐2 surveillance in Norway rats ( Rattus norvegicus ) from Antwerp sewer system, Belgium
Colombo, V. C., Sluydts, V., Mariën, J., Broecke, B. V., Houtte, N. V., Leirs, W., Jacobs, L., Iserbyt, A., Hubert, M., Heyndríckx, L., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14219 · Cited by 40
Nanoparticle approaches against SARS-CoV-2 infection
Duan, Y., Wang, S., Zhang, Q., Gao, W., & Zhang, L. (2021) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2021.100964 · Cited by 43
Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
Sun, J., Min, Y., Li, Y., Sun, X., Dèng, F., Wáng, H., & Ning, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.797189 · Cited by 42
Self-citationRen, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Kenney, D., O’Connell, A. K., Zhang, Y. L., Zhong, J., et al. (2022) · mBio · doi:10.1128/mbio.00099-22 · Cited by 41
Self-citationCross-Species Tropism and Antigenic Landscapes of Circulating SARS-CoV-2 Variants
Zhang, Y., Wei, M., Wu, Y., Wang, J., Hong, Y., Huang, Y., Yuan, L., Ma, J., Wang, K., Wang, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.110558 · Cited by 40
Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review
Ehaideb, S. N., Abdullah, M. L., Abuyassin, B., & Bouchama, A. (2020) · Critical Care · doi:10.1186/s13054-020-03304-8 · Cited by 44
Lu, L., Chu, A. W., Zhang, R., Chan, W.-M., Ip, J. D., Tsoi, H., Chen, L., Cai, J., Lung, D. C., Tam, A. R., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103544 · Cited by 39
Yu, Y., Esposito, D., Kang, Z., Lü, J., Remaley, A. T., Giorgi, V. D., Chen, L. N., West, K. A., & Cao, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-06629-2 · Cited by 42
Genetically modified mouse models to help fight COVID-19
Gurumurthy, C. B., Quadros, R. M., Richardson, G. P., Poluektova, L. Y., Mansour, S. L., & Ohtsuka, M. (2020) · Nature Protocols · doi:10.1038/s41596-020-00403-2 · Cited by 41
Pereira, F. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.080 · Cited by 42
Zelyas, N. J., Pabbaraju, K., Croxen, M. A., Lynch, T., Buss, E., Murphy, S. A., Shokoples, S., Wong, A. A., Kanji, J. N., & Tipples, G. A. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00315-21 · Cited by 38
SARS-CoV-2 immunity in animal models
Chen, Z., Yuan, Y., Hu, Q., Zhu, A., Chen, F., Li, S., Guan, X., Lv, C., Tang, T., He, Y., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01122-w · Cited by 42
Self-citationThe localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York State
Lasek-Nesselquist, E., Lapierre, P., Schneider, E., George, K. S., & Pata, J. (2021) · medRxiv · doi:10.1101/2021.02.26.21251868 · Cited by 37
Napolitano, F., Xu, X., & Gao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab456 · Cited by 42
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
Tan, Z. W., Tee, W.-V., Samsudin, F., Guarnera, E., Bond, P. J., & Berezovsky, I. N. (2022) · Structure · doi:10.1016/j.str.2021.12.011 · Cited by 38
Ren, W., Zhu, Y., Wang, Y., Shi, H., Yin, Y., Hu, G., Feng, F., Zhao, X., Lan, J., Wu, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009392 · Cited by 49
Self-citationCommon Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
Kant, R., Kareinen, L., Smura, T., Freitag, T. L., Jha, S. K., Alitalo, K. K., Meri, S., Sironen, T. A., Saksela, K., Strandin, T. M., et al. (2021) · Viruses · doi:10.3390/v13112263 · Cited by 37
Spherical neutralizing aptamer suppresses SARS-CoV-2 Omicron escape
Sun, M., Wu, Z., Zhang, J., Chen, M., Lu, Y. W. W., Yang, C. J., & Song, Y. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101499 · Cited by 38
SARS-CoV-2 variants: Impact on biological and clinical outcome
Mahilkar, S., Agrawal, S. R., Chaudhary, S., Parikh, S., Sonkar, S. C., Verma, D. K., Chitalia, V., Mehta, D., Koner, B. C., Vijay, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995960 · Cited by 43
Amruta, N., Ismael, S., Leist, S. R., Gressett, T. E., Srivastava, A., Dinnon, K. H., Engler-Chiurazzi, E. B., Maness, N. J., Qin, X., Kolls, J. K., et al. (2022) · Viruses · doi:10.3390/v15010114 · Cited by 38
Host range, transmissibility and antigenicity of a pangolin coronavirus
Hou, Y. J., Chiba, S., Leist, S. R., Meganck, R. M., Martinez, D. R., Schäfer, A., Catanzaro, N., Sontake, V., West, A., Edwards, C. E., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01476-x · Cited by 43
Tu, H., Avenarius, M. R., Kubatko, L. S., Hunt, M., Pan, X., Ru, P., Garee, J. P., Thomas, K., Mohler, P. J., Pancholi, P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.12.426407 · Cited by 39
The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
Li, C., Tian, X., Jia, X., Wan, J., Lu, L., Jiang, S., Lan, F., Lu, Y., Wu, Y., & Ying, T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00536-0 · Cited by 37
Self-citationMapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2
Thomas, S. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2020.0627 · Cited by 35
Animal models for SARS‐CoV‐2 infection and pathology
Bi, Z., Hong, W., Yang, H. J., Lu, S., & Peng, X. (2021) · MedComm · doi:10.1002/mco2.98 · Cited by 36
Lai, X., Yu, Y., Xian, W., Ye, F., Ju, X., Luo, Y., Dong, H., Zhou, Y., Tan, W., Zhuang, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104136 · Cited by 36
Self-citationDouble lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
Zhu, L., Deng, Y., Zhang, R.-R., Cui, Z., Sun, C.-Y., Fan, C., Xing, X., Huang, W., Chen, Q., Zhang, N.-N., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa297 · Cited by 35
Self-citationGenomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., Mayer, A. D. M., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07708-w · Cited by 38
SARS-CoV-2 and pathological matrix remodeling mediators
Guizani, I., Fourti, N., Zidi, W., Feki, M., & Elasmi, M. (2021) · Inflammation Research · doi:10.1007/s00011-021-01487-6 · Cited by 39
Du, S., Liu, P., Zhang, Z., Xiao, T., Yasimayi, A., Huang, W., Wang, Y., Cao, Y., Xie, X. S., & Xiao, J. (2021) · Cell Research · doi:10.1038/s41422-021-00555-0 · Cited by 35
Self-citationMolecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
Su, C., He, J., Han, P., Bai, B., Li, D., Cao, J. X., Tian, M., Hu, Y., Zheng, A., Niu, S., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00814-22 · Cited by 34
Self-citationIdentification of the metaphyseal skeletal stem cell building trabecular bone
Yang, G., He, Q., Guo, X., Li, R., Lin, J., Tao, W., Liu, W., Liu, W., Tang, M., Xing, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl2238 · Cited by 38
Self-citationThe search for animals harbouring coronavirus — and why it matters
Mallapaty, S. (2021) · Nature · doi:10.1038/d41586-021-00531-z · Cited by 33
Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
Shukla, N., Roelle, S. M., Suzart, V. G., Bruchez, A. M., & Matreyek, K. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009715 · Cited by 39
Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease
Keep, S., Carr, B. V., Lean, F. Z. X., Fones, A., Newman, J., Dowgier, G., Freimanis, G., Vatzia, E., Polo, N., Everest, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867707 · Cited by 36
Stone, S., Rothan, H. A., Natekar, J. P., Kumari, P., Sharma, S., Pathak, H., Arora, K., Auroni, T. T., & Kumar, M. (2021) · Viruses · doi:10.3390/v14010027 · Cited by 35
Yan, K., Dumenil, T. D., Tang, B., Le, T. T., Bishop, C., Suhrbier, A., & Rawle, D. J. (2022) · Virus Evolution · doi:10.1093/ve/veac063 · Cited by 34
Spinello, A., Saltalamacchia, A., Borišek, J., & Magistrato, A. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c01415 · Cited by 38
Selection of animal models for COVID-19 research
Kumar, S., Yadav, P. K., Srinivasan, R., & Nagarajan, P. (2020) · VirusDisease · doi:10.1007/s13337-020-00637-4 · Cited by 36
Yang, C., Pan, X., Huang, Y., Cheng, C., Xu, X., Wu, Y., Xu, Y., Shang, W., Niu, X., Wan, Y., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000224 · Cited by 35
Cheng, L., Song, S., Zhou, B., Ge, X., Yu, J., Zhang, M., Ju, B., & Zhang, Z. (2021) · Virology Journal · doi:10.1186/s12985-021-01554-8 · Cited by 42
Yu, D., Zhu, Y., Jiao, T., Wu, T. T., Xiao, X., Qin, B., Chong, H., Lei, X., Ren, L., Cui, S., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1937329 · Cited by 33
Self-citationNair, M. S., Huang, Y., Fidock, D. A., Towler, M. J., & Weathers, P. J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114797 · Cited by 32
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Kaleta, T., Kern, L., Hong, S. L., Hölzer, M., Kochs, G., Beer, J., Schnepf, D., Schwemmle, M., Bollen, N., Kolb, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28766-y · Cited by 36
Davis, M., Voss, K., Turnbull, J. B., Gustin, A. T., Knoll, M. L., Muruato, A. E., Hsiang, T.-Y., Dinnon, K. H., Leist, S. R., Nickel, K., et al. (2022) · Vaccines · doi:10.3390/vaccines11010047 · Cited by 32
Wang, X., Wang, W., Wang, T., Wang, J., Jiang, Y., Wang, X., Qiu, Z., Feng, N., Sun, W., Li, C., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00011-23 · Cited by 32
Self-citationChu, J. T. S., & Lamers, M. M. (2024) · npj Viruses · doi:10.1038/s44298-024-00017-5 · Cited by 36
Evolution of Antiviral Drug Resistance in SARS-CoV-2
Dinata, R., Baindara, P., & Mandal, S. M. (2025) · Viruses · doi:10.3390/v17050722 · Cited by 34
COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
Joma, M., Fovet, C.-M., Seddiki, N., Gressèns, P., & Laforge, M. (2021) · Vaccines · doi:10.3390/vaccines9040391 · Cited by 34
Buchan, S. A., Tibebu, S., Daneman, N., Whelan, M., Vanniyasingam, T., Murti, M., & Brown, K. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab496 · Cited by 31
Malherbe, D. C., Kurup, D., Wirblich, C., Ronk, A. J., Mire, C. E., Kuzmina, N. A., Shaik, N. F., Periasamy, S., Hyde, M. A., Williams, J. M., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00352-1 · Cited by 32
Xu, Z., Kang, X., Han, P., Du, P., Li, L., Zheng, A., Deng, C., Qi, J., Zhao, X., Wang, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31276-6 · Cited by 33
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model
Nobori, H., Fukao, K., Kuroda, T., Anan, N., Tashima, R., Nakashima, M., Noda, S., Tajiri, M., Torii, M., Toba, S., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac257 · Cited by 31
SARS CoV-2 infections in animals, two years into the pandemic
Frazzini, S., Amadori, M., Turin, L., & Riva, F. (2022) · Archives of Virology · doi:10.1007/s00705-022-05609-1 · Cited by 33
Pandamooz, S., Jurek, B., Meinung, C.-P., Baharvand, Z., Shahem-abadi, A. S., Haerteis, S., Miyan, J. A., Downing, J. E., Dianatpour, M., Borhani‐Haghighi, A., et al. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-121120-012309 · Cited by 32
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Singh, B., Mal, G., Verma, V., Tiwari, R., Khan, M. I., Mohapatra, R. K., Mitra, S., Alyami, S. A., Emran, T. B., Dhama, K., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02334-5 · Cited by 31
Origin, evolution and global spread of SARS-CoV-2
Zhukova, A., Blassel, L., Lemoine, F., Morel, M. H., Voznica, J., & Gascuel, O. (2020) · Comptes Rendus Biologies · doi:10.5802/crbiol.29 · Cited by 36
Community-level SARS-CoV-2 sequence diversity revealed by wastewater sampling
Swift, C. L., Isanovic, M., Velez, K. E. C., & Norman, R. S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149691 · Cited by 31
Mouse Models for the Study of SARS-CoV-2 Infection
Knight, A. C., Montgomery, S. A., Fletcher, C., & Baxter, V. K. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000031 · Cited by 34
Single domain shark VNAR antibodies neutralize SARS‐CoV‐2 infection in vitro
Gauhar, A., Privezentzev, C. V., Demydchuk, M., Gerlza, T., Rieger, J., Kungl, A. J., Walsh, F. S., Rutkowski, J. L., & Stocki, P. (2021) · The FASEB Journal · doi:10.1096/fj.202100986rr · Cited by 30
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
Bi, Z., Hong, W., Que, H., He, C., Ren, W., Yang, J., Lu, T., Chen, L., Lu, S., Peng, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00851-6 · Cited by 35
Li, R., Ma, X., Deng, J., Chen, Q., Liu, W., Peng, Z., Qiao, Y., Lin, Y., He, X., & Zhang, H. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00641-8 · Cited by 30
Self-citationSARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
Wang, R., Zhang, Q., Zhang, R., Aw, Z. Q., Chen, P., Wong, Y. H., Hong, J., Ju, B., Shi, X., Ding, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.854952 · Cited by 32
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
Liu, S., Selvaraj, P., Sangare, K., Luan, B., & Wang, T. T. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111359 · Cited by 30
After the virus has cleared—Can preclinical models be employed for Long COVID research?
Jansen, E. B., Orvold, S. N., Swan, C. L., Yourkowski, A., Thivierge, B. M., Francis, M. E., Ge, A., Rioux, M. L., Darbellay, J., Howland, J. G., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010741 · Cited by 29
Bader, S. M., Cooney, J. P., Sheerin, D., Taiaroa, G., Harty, L., Davidson, K. C., Mackiewicz, L., Dayton, M., Wilcox, S., Whitehead, L. W., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301689120 · Cited by 30
van der Wijst, M. G. P., Vazquez, S. E., Hartoularos, G. C., Bastard, P., Grant, T., Bueno, R., Lee, D. S., Greenland, J. R., Sun, Y., Perez, R. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.09.434529 · Cited by 34
Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants
Jukič, M., Škrlj, B., Tomšič, G., Pleško, S., Podlipnik, Č., & Bren, U. (2021) · Molecules · doi:10.3390/molecules26103003 · Cited by 31
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.